St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: vandetanib

First Posted Date: 2007-05-10

Last Posted Date: 2012-10-15

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 35

Registration Number: NCT00472017

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

Phase 2

Completed

Conditions: Hodgkin's Lymphoma

Interventions: Drug: Adriamycin®
Drug: Vinblastine
Drug: Nitrogen Mustard
Drug: Cyclophosphamide
Drug: Vincristine
Drug: Bleomycin
Drug: Etoposide
Drug: Prednisone
Biological: G-CSF
Procedure: Radiotherapy

First Posted Date: 2006-07-14

Last Posted Date: 2023-09-22

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 81

Registration Number: NCT00352027

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Stanford University Medical Center, Palo Alto, California, United States
🇺🇸
Rady Children's Hospital San Diego, San Diego, California, United States

and more 3 locations

Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease

Completed

Conditions: Sickle Cell Disease

First Posted Date: 2006-03-21

Last Posted Date: 2020-07-28

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 260

Registration Number: NCT00305175

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias

Not Applicable

Completed

Conditions: Diamond-Blackfan Anemia
Kostmann Syndrome
Amegakaryocytic Thrombocytopenia
Anemia, Aplastic

Interventions: Device: Allogeneic stem cell transplant

First Posted Date: 2005-10-25

Last Posted Date: 2017-05-30

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 4

Registration Number: NCT00244010

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor

Phase 2

Completed

Conditions: Wilms Tumor

Interventions: Drug: Topotecan, Filgrastim (G-CSF), Pegfilgrastim

First Posted Date: 2005-09-16

Last Posted Date: 2008-06-04

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 37

Registration Number: NCT00187031

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇨🇦
Hospital of Sick Children, Toronto, Ontario, Canada
🇨🇦
Tom Baker Cancer Center, Calgary, Alberta, Canada

and more 4 locations

Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL

Phase 2

Completed

Conditions: Non-Hodgkin Lymphoma
Acute Lymphoblastic Leukemia, Mature B-Cell

Interventions: Drug: Prednison, Vincristine, Cytarabine, Methotrexate, Etoposide, Cyclophosphamide, Doxorubicin

First Posted Date: 2005-09-16

Last Posted Date: 2008-06-04

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 68

Registration Number: NCT00187161

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease

Phase 2

Completed

Conditions: Sickle Cell Disease

Interventions: Drug: Busulfan, Cyclophosphamide, Horse ATG
Procedure: Allogeneic stem cell transplant

First Posted Date: 2005-09-16

Last Posted Date: 2009-05-29

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 15

Registration Number: NCT00186810

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Therapy for Children With Advanced Stage High Risk Neuroblastoma

Phase 2

Completed

Conditions: Neuroblastoma

Interventions: Drug: Topotecan, Cyclophosphamide, Cisplatin, Doxorubicin, Etoposide, Ifosfamide, Carboplatin
Procedure: Peripheral Blood Stem Cell Transplant

First Posted Date: 2005-09-16

Last Posted Date: 2009-05-20

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 30

Registration Number: NCT00186849

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

Phase 3

Completed

Conditions: Leukemia, Acute Lymphocytic (ALL)
Leukemia, Myeloid, Acute(AML)
Leukemia, Myeloid, Chronic(CML)
Juvenile Myelomonocytic Leukemia(JMML)
Hemoglobinuria, Paroxysmal Nocturnal (PNH)
Lymphoma, Non-Hodgkin (NHL)
Myelodysplastic Syndrome (MDS)

Interventions: Device: Miltenyi Biotec CliniMACS
Procedure: Stem Cell Transplantation

First Posted Date: 2005-09-16

Last Posted Date: 2009-01-29

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 57

Registration Number: NCT00186823

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects

Phase 2

Completed

Conditions: Brain Tumors
Central Nervous System Tumors

Interventions: Procedure: Radiation Therapy

First Posted Date: 2005-09-16

Last Posted Date: 2023-05-31

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 361

Registration Number: NCT00187226

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy